MedTrace Logo

Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients

NCT04372576 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2020-05-04

No results posted yet for this study

Summary

The aim of this study is to determine the risk factors for development of ventilator-associated pneumonia (VAP) and to identify the prognostic factors of VAP among Coronavirus Disease 2019 (CoViD-19) patients. We hypothesized that CoViD-19 serves as a high risk factor for the development of VAP and it affects clinical outcome measures negatively.

Conditions

  • Ventilator Associated Pneumonia
  • Corona Virus Infection

Interventions

DIAGNOSTIC_TEST

Assessment of ventilator-associated pneumonia criteria

Diagnosis of ventilator-associated pneumonia is based upon the routine daily clinical and laboratory parameters.

Sponsors & Collaborators

  • Semmelweis University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-16
Primary Completion
2020-08-31
Completion
2020-08-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04372576 on ClinicalTrials.gov